Local Medical Device Company, NuVasive(R), Sponsors the 6th Annual San Diego Festival of Science and Engineering Expo Day

SAN DIEGO, CA--(Marketwired - Mar 21, 2014) - NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, is excited to sponsor the 6^th Annual San Diego Festival of Science and Engineering EXPO Day on Saturday, March 22, 2014 from 10:00 a.m. to 5:00 p.m. at PETCO Park, booths #P10 and P12.

The San Diego Festival of Science and Engineering EXPO Day is the city's largest celebration of science, offering thousands of students and their families the opportunity to "excite their minds" with more than 100 hands-on interactive science experiments.

As a local medical device company that is a global leader in minimally invasive surgery, NuVasive is passionate about encouraging children of all ages to explore the fields of Science, Technology, Engineering and Math (STEM) to further their interest in innovation.

"EXPO day is a great opportunity for young children and adults to explore the possibilities of innovation," said Alex Lukianov, NuVasive Chairman and Chief Executive Officer. "As a parent myself, I am excited to introduce children to the power of science and to demonstrate the life-changing capabilities that it can have. In our mission to change spine surgery, we rely heavily on science to constantly invent new and innovative technology that can improve patient lives and surgical outcomes."

Over the last decade, NuVasive has built a procedurally integrated portfolio with more than 90 products and procedures that address all areas of the spine, spanning lumbar, thoracic, and cervical applications.

The Company has changed hundreds of thousands of patient lives with game-changing solutions like the eXtreme Lateral Interbody Fusion (XLIF^®) procedure. The XLIF procedure is an innovative approach for spine fusion, which accesses the spine from the side of the body as opposed to traditional fusions, which access the spine from the patient's front or back. The XLIF approach can reduce trauma to the patient and has the potential to treat pathologies that could not previously be treated.

XLIF patients are often able to walk the same day of surgery, suffer less blood loss, spend less time in the hospital, and are back to their daily activities within four to six weeks. By comparison, a traditional "open" spine fusion surgery typically requires a larger incision, resulting in significantly longer recovery times and increased blood loss.